Thomas Patrick Kelly, Chief Financial Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 1,368 shares at $9.05 ($12K) on 2022-02-16, disclosed to the SEC on 2022-02-18.
Seasonal sale ($12k) by Chief Financial Officer — this insider has traded DCPH in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-06-21 | $24K | — | Filing → |